Novartis Investigative Site

Bhubaneswar, Odisha 751007

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Early Breast Cancer, Metastatic Breast Cancer, Sickle Cell Disease (SCD)

Studies at this site

• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
• Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients — Running, not enrolling
• Roll-over Study to Allow Continued Access to Ribociclib — Running, not enrolling
• Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer — Completed